Journal of Surgical Oncology · 2011 · 32 citations · 20 references
MedicineOncologyUrologyMolecular OncologyNeoplasiaTumor ProgressionBladder CancerCancer EpigenomicsCancer ProgressionCancer StagingEpigenetic Alterations In CancerMalignant NeoplasmsAberrant Dna MethylationClinicopathological CorrelationDisease Progression PredictionKaplan-meier Survival EstimatesPromoter HypermethylationTumor Grade AssessmentTumor Grade ClassificationTumor Stage Prognosis
BACKGROUND AND OBJECTIVES: We have previously reported that RUNX3 inactivation by promoter hypermethylation correlated with advanced disease and poor clinical outcome in bladder cancer. In this study, we examined primary tumors from non-muscle-invasive bladder cancer (NMIBC) patients in order to investigate the relationship between RUNX3 methylation and disease progression. METHODS: The association between the hypermethylation of RUNX3 and clinicopathological characteristics of 186 NMIBC samples was analyzed using methylation-specific polymerase chain reaction (MS-PCR). RESULTS: RUNX3 methylation was associated with increased tumor stage, grade, and number of tumors (each P < 0.05). Kaplan-Meier estimates revealed significant differences in time to recurrence and progression based on RUNX3 methylation status (P = 0.043 and 0.006, respectively). RUNX3 methylation was an independent predictor of NMIBC progression on univariate and multivariate analysis. Combining tumor grade and RUNX3 methylation status demonstrated that patients with G3 tumors with RUNX3 methylation had a worse progression-free survival compared with the patients with lower-grade or unmethylated tumors [hazard ratio (HR), 19.450]. CONCLUSIONS: RUNX3 methylation status predicted the risk of NMIBC progression independently of tumor stage. In conjunction with tumor grade, RUNX3 methylation status in patients with NMIBC strongly predicts disease progression.
20
Richard Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck et al. · European Urology · 2006 · 3K citations
Maurizio Brausi, Laurence Collette, Karl‐Heinz Kurth et al. · European Urology · 2002 · 683 citations
Luc Girard, Sabine Zöchbauer‐Müller, A K Virmani et al. · PubMed · 2000 · 345 citations